Protocol for analysis of miRNAs in human melanoma cells

Evelyn Lattmann1, Tessa Guggiari1, Patrick Turko1

  • 1Department of Dermatology, University of Zurich, University Hospital Zurich, 8952 Schlieren, Switzerland.

STAR Protocols
|May 31, 2025
PubMed

Insights

This study presents a protocol for analyzing microRNAs (miRNAs) in human melanoma cells, focusing on expression and co-localization. The method aids in understanding melanoma plasticity, metastasis, and therapy resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play a crucial role in melanoma's ability to change and adapt, which drives its spread and resistance to treatment.
  • Understanding miRNA expression is vital for developing new melanoma therapies.

Purpose of the Study:

  • To provide a detailed protocol for the analysis of microRNAs in human melanoma cells.
  • To establish methods for quantifying miRNA expression and co-localization within melanoma cells.

Main Methods:

  • The protocol details two cell-plating techniques: using cell chambers or slide-based centrifugation.
  • It outlines cell pretreatment and staining using the RNAscope Plus small RNA-RNA high-definition (smRNA-RNA HD) assay.
  • Quantitative analysis of miRNA expression and co-localization is described.

Main Results:

  • The protocol enables precise analysis of miRNA expression patterns in melanoma cells.
  • It allows for the assessment of miRNA co-localization, providing insights into their regulatory networks.
  • The RNAscope Plus smRNA-RNA HD assay is utilized for high-definition visualization.

Conclusions:

  • This protocol offers a robust method for studying microRNAs in melanoma.
  • It supports research into melanoma plasticity, metastasis, and therapeutic resistance mechanisms.
  • The findings facilitate a deeper understanding of miRNA's role in melanoma progression.